rs373512514
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_178452.6(DNAAF1):āc.115T>Cā(p.Cys39Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000284 in 1,548,140 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_178452.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAAF1 | NM_178452.6 | c.115T>C | p.Cys39Arg | missense_variant | 1/12 | ENST00000378553.10 | NP_848547.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAAF1 | ENST00000378553.10 | c.115T>C | p.Cys39Arg | missense_variant | 1/12 | 1 | NM_178452.6 | ENSP00000367815.5 | ||
DNAAF1 | ENST00000567918.5 | n.115T>C | non_coding_transcript_exon_variant | 1/7 | 1 | ENSP00000455154.1 | ||||
DNAAF1 | ENST00000563093.5 | n.115T>C | non_coding_transcript_exon_variant | 1/11 | 2 | ENSP00000457373.1 | ||||
DNAAF1 | ENST00000570298.5 | n.269T>C | non_coding_transcript_exon_variant | 1/11 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 151996Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000266 AC: 4AN: 150434Hom.: 0 AF XY: 0.0000125 AC XY: 1AN XY: 79880
GnomAD4 exome AF: 0.0000129 AC: 18AN: 1396144Hom.: 0 Cov.: 31 AF XY: 0.0000145 AC XY: 10AN XY: 688736
GnomAD4 genome AF: 0.000171 AC: 26AN: 151996Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74228
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 05, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 13, 2023 | This sequence change replaces cysteine, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 39 of the DNAAF1 protein (p.Cys39Arg). This variant is present in population databases (rs373512514, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with DNAAF1-related conditions. ClinVar contains an entry for this variant (Variation ID: 525446). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The arginine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at